UBS Group AG - CUREVAC N V ownership

CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 117 filers reported holding CUREVAC N V in Q3 2021. The put-call ratio across all filers is 2.16 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS Group AG ownership history of CUREVAC N V
ValueSharesWeighting
Q3 2023$516,048
-44.2%
75,556
-14.9%
0.00%
Q2 2023$924,838
-21.1%
88,756
-47.3%
0.00%
Q1 2023$1,172,829
+125.4%
168,268
+95.0%
0.00%
Q4 2022$520,413
+9.6%
86,304
+43.4%
0.00%
Q3 2022$475,000
+17.9%
60,201
+102.9%
0.00%
Q2 2022$403,000
+17.8%
29,676
+70.2%
0.00%
Q1 2022$342,000
-42.5%
17,437
+0.6%
0.00%
Q4 2021$595,000
-30.5%
17,334
+10.5%
0.00%
Q3 2021$856,000
-95.1%
15,688
-93.3%
0.00%
-100.0%
Q2 2021$17,325,000
+4659.6%
235,775
+5816.6%
0.01%
Q1 2021$364,000
+26.4%
3,985
+11.9%
0.00%
Q4 2020$288,000
+405.3%
3,561
+193.1%
0.00%
Q3 2020$57,0001,2150.00%
Other shareholders
CUREVAC N V shareholders Q3 2021
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 3,134,780$286,707,00046.92%
Ally Bridge Group (NY) LLC 110,000$10,061,0001.93%
Parametrica Management Ltd 44,695$3,968,0001.91%
Renaissance Capital LLC 123,983$11,339,0001.68%
Samsara BioCapital, LLC 95,318$8,718,0001.61%
Ikarian Capital, LLC 360,000$32,925,0001.11%
SECTOR GAMMA AS 25,000$2,287,0000.42%
Fosun International Ltd 50,000$4,438,0000.35%
Ikarian Capital, LLC 100,000$9,145,0000.31%
Baillie Gifford 5,830,101$533,221,0000.30%
View complete list of CUREVAC N V shareholders